Brighton Jones LLC’s Matinas BioPharma MTNB Stock Holding History

Brighton Jones LLC’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$6K	–	502
2022 Q3	$6K	Hold	200	–	–	﹤0.01%	466
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	473
2022 Q1	$8K	Hold	200	–	–	﹤0.01%	515
2021 Q4	$10K	Hold	200	–	–	﹤0.01%	530
2021 Q3	$13K	Hold	200	–	–	﹤0.01%	487
2021 Q2	$8K	Hold	200	–	–	﹤0.01%	480
2021 Q1	$11K	Hold	200	–	–	﹤0.01%	430
2020 Q4	$14K	Hold	200	–	–	﹤0.01%	395
2020 Q3	$8K	Sell	200 -1,600	-89%	-$63.6K	﹤0.01%	332
2020 Q2	$70K	Hold	1,800	–	–	0.01%	290
2020 Q1	$54K	Buy	1,800 +800	+80%	+$48.3K	0.01%	271
2019 Q4	$114K	Hold	1,000	–	–	0.01%	311
2019 Q3	$32K	Hold	1,000	–	–	﹤0.01%	306
2019 Q2	$43K	Hold	1,000	–	–	0.01%	302
2019 Q1	$55K	Buy	+1,000	New	+$53.9K	0.01%	299

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Brighton Jones LLC's MTNB Position: Q4 2022 in Review

Brighton Jones LLC sold out of Matinas BioPharma (MTNB) in Q4 2022, closing a stake of 200 shares — an estimated $6K sold.

Brighton Jones LLC first reported a position in MTNB in Q1 2019 and held it in 15 quarters. The position peaked at $114K in Q4 2019. 57 funds tracked by Wall St. Rank hold MTNB as of Q4 2022.

Brighton Jones LLC reported no remaining Matinas BioPharma position as of Q4 2022 after selling out during the quarter.
Brighton Jones LLC sold 200 Matinas BioPharma shares in Q4 2022, an estimated $6K.
Brighton Jones LLC first reported a position in Matinas BioPharma in Q1 2019 and held it in 15 quarters.
Brighton Jones LLC's Matinas BioPharma position peaked at $114K in Q4 2019.
57 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2022.

Based on Brighton Jones LLC's 13F filing for Q4 2022, filed 3 Feb 2023.